'Foxp3' presentation slideshows

Immunity April ? 2009

? ? ? T ? ? ? ? ? ? ??? ??????? 2009.12.11 ??. CD4 + CD25 + Foxp3 + Tregs. Immunity April ? 2009. Other types of regulatory T cells. Tr1: Producing IL-10 after Ag triggering NKT: Secret IL-4 after activation

931 views • 77 slides

S ymbiont- A ssociated M olecular P atterns

723 views • 50 slides

Scurfy Mouse (outside)

Scurfy Mouse (outside). Wild type. Scurfy. X-linked recessive inheritance Lethality at 21-25 days Wasting syndrome Exfoliative dermatitis Small, thickened ears. Scurfy Mouse (inside). Wild type. Scurfy. Severe autoimmune disorder

954 views • 45 slides

ENISI Tool Suite

ENISI Tool Suite. Yongguo Mei PhD in ECE June 10, 2014. ENISI Tool Suite. ENISI: ENteric Immune SImulator A suite of mathematical and computational modeling tools, inclduing ENISI ABM Agent-based modeling (covered) ENISI SDE, stochastic differential equations

506 views • 35 slides

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHRONIC OBSTRUCTIVE PULMONARY DISEASE. ZULEYHA OZEN. OVERVIEW. Introduction Information about Chronic Obstructive Pulmonary Disease (COPD ) Inflammatory Responses Paper 1 Paper 2 What is still unknown? Future Studies/Specific Aim. Disease Overview.

638 views • 30 slides

FOXP3-mediated Transcriptional Regulation of MicroRNAs in Breast Cancer

FOXP3-mediated Transcriptional Regulation of MicroRNAs in Breast Cancer. Department of Genetics University of Alabama at Birmingham Runhua Liu, M.D & Ph.D. 09/2017. Outlines FOXP3 is an X-linked tumor suppressor gene in breast cancer FOXP3-miR-146-NFkB axis and its role in breast cancer

306 views • 29 slides

Fraction of wells with no tumor growth

a). 1in 9x10 5 5.955216 + 0.1316621. 1 in 6.5x10 4 4.814143 + 0.13267116. b). 1 in 1.7x10 6 6,237557 + 0.2496739. Fraction of wells with no tumor growth. 1 in 1.5x10 5 5.183771 + 0.08384. c). 1 in 9.8x10 4 4.992655 + 0.08906144. 1 in 5x10 4 4.701321 + 0.3093.

114 views • 4 slides

Foxp3

2.5. 16.5. 2.3. 5.3. 2.9. 2.4. 24. 71. 4.6. 23.4. 18. 9.4. 13.4. 13.9. 12. 23. 6. WT T con. WT T reg. +-. +IL2. +IL4. +IL7. 76. WT. Bim -/-. ***. 30. 100. % CD25 + Foxp3 + (in CD4 + cells). Count. 80. 20. Bim -/- T con. Bim -/- T reg. 60. Viability(%).

124 views • 1 slides